Delaware | 1-31719 | 13-4204626 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
200 Oceangate, Suite 100, Long Beach, California 90802 |
(Address of principal executive offices) |
Emerging growth company | ¨ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act. | |
¨ |
Exhibit No. | Description |
99.1 | Press release of Molina Healthcare, Inc., issued April 29, 2019, as to financial results for the first quarter ended March 31, 2019, and raising the Company’s full year 2019 earnings guidance. |
99.2 | Slide Presentation entitled “2019 1Q Earnings Call Supplement,” dated April 29, 2019. |
MOLINA HEALTHCARE, INC. | |||
Date: | April 29, 2019 | By: | /s/ Jeff D. Barlow |
Jeff D. Barlow | |||
Chief Legal Officer and Secretary |
Exhibit No. | Description |
Slide Presentation entitled “2019 1Q Earnings Call Supplement,” dated April 29, 2019. |
• | Net income per diluted share was $2.99 in the first quarter of 2019 compared with $1.64 in the first quarter of 2018, which included a net benefit of $0.38 per diluted share for non-run-rate items |
• | After-tax margin improved to 4.8% in the first quarter of 2019 compared with 2.3% in the first quarter of 2018 |
• | Medical care ratio was 85.3% in the first quarter, an improvement from 87.7% in the first quarter of 2018, excluding non-run-rate items in the first quarter of 2018 |
• | Premium revenue was $4.0 billion in the first quarter of 2019, a 9% decrease compared with the first quarter of 2018, which was in line with the Company’s expectations |
• | The Company raised full year 2019 earnings guidance to $10.50 - $11.00 from $9.25 - $9.75, which does not include any future prior-period reserve development |
• | The Medicaid MCR was 88.5% in the first quarter of 2019, an improvement compared with 90.8% in the first quarter of 2018. This was mainly due to improvements in the Temporary Assistance for Needy Families and Aged, Blind or Disabled programs, partially offset by an increased MCR in the Medicaid Expansion program, primarily in California and Ohio. |
• | The Marketplace MCR was 62.2% in the first quarter of 2019, compared with 50.6% in the first quarter of 2018. The prior year MCR was positively impacted by the benefit of the CSR, without which the Marketplace MCR would have been 66.8% in the first quarter of 2018. The year-over-year improvement primarily reflected increased premium revenue related to rate increases and risk scores that are more commensurate with the acuity of the Company’s Marketplace population. |
2019 Revised Guidance | 2019 Initial Guidance | |||
Premium revenue | ~$15.9B | ~$15.8B | ||
Premium tax revenue | ~$425M | ~$375M | ||
Investment income and other revenue | ~$115M | ~$195M | ||
Total revenue | ~$16.4B | ~$16.3B | ||
Medical care costs | ~$13.6B | ~$13.7B | ||
Medical care ratio (2) | ~86% | 86.7% - 87.0% | ||
General and administrative expenses | ~$1.3B | ~$1.2B | ||
G&A ratio (3) | ~7.7% | 7.5% - 7.7% | ||
Premium tax expenses | ~$425M | ~$375M | ||
Depreciation and amortization | ~$90M | ~$85M | ||
Interest expense and other expenses, net | ~$90M | ~$100M | ||
Income before income taxes | $900M - $940M | $790M - $840M | ||
Net income | $680M - $710M | $600M - $630M | ||
EBITDA (4) | $1,080M - $1,120M | $975M - $1,025M | ||
Effective tax rate | ~24.5% | 24.5% - 25.0% | ||
After-tax margin (3) | 4.1% - 4.3% | 3.7% - 3.9% | ||
Diluted weighted average shares | ~64.7M | ~64.7M | ||
Net income per share | $10.50 - $11.00 | $9.25 - $9.75 | ||
End-of-year membership by government program: | ||||
Medicaid and Medicare | ~3.1M | ~3.2M | ||
Marketplace | 270K - 280K | 250K - 275K |
(1) | All amounts are estimates and do not include non-recurring significant items. Earnings per diluted share as shown is calculated on a GAAP basis; actual results may differ materially. See the Company’s risk factors as discussed in its 2018 Form 10-K and other filings and the statements below in this press release after the heading “Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995.” |
(2) | Medical care ratio represents medical care costs as a percentage of premium revenue. |
(3) | G&A ratio represents general and administrative expenses as a percentage of total revenue. After-tax margin represents net income as a percentage of total revenue. |
(4) | See reconciliation of non-GAAP financial measures at the end of this release. |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(In millions, except per-share amounts) | |||||||
Revenue: | |||||||
Premium revenue | $ | 3,952 | $ | 4,323 | |||
Premium tax revenue | 138 | 104 | |||||
Health insurer fees reimbursed | — | 61 | |||||
Service revenue | — | 134 | |||||
Investment income and other revenue | 29 | 24 | |||||
Total revenue | 4,119 | 4,646 | |||||
Operating expenses: | |||||||
Medical care costs | 3,371 | 3,722 | |||||
General and administrative expenses | 302 | 352 | |||||
Premium tax expenses | 138 | 104 | |||||
Health insurer fees | — | 75 | |||||
Depreciation and amortization | 25 | 26 | |||||
Restructuring costs | 3 | 25 | |||||
Cost of service revenue | — | 120 | |||||
Total operating expenses | 3,839 | 4,424 | |||||
Operating income | 280 | 222 | |||||
Other expenses, net: | |||||||
Interest expense | 23 | 33 | |||||
Other (income) expenses, net | (3 | ) | 10 | ||||
Total other expenses, net | 20 | 43 | |||||
Income before income tax expense | 260 | 179 | |||||
Income tax expense | 62 | 72 | |||||
Net income | $ | 198 | $ | 107 | |||
Net income per diluted share | $ | 2.99 | $ | 1.64 | |||
Diluted weighted average shares outstanding | 66.2 | 65.2 | |||||
Operating Statistics: | |||||||
Medical care ratio | 85.3 | % | 86.1 | % | |||
G&A ratio | 7.3 | % | 7.6 | % | |||
Premium tax ratio | 3.4 | % | 2.3 | % | |||
Effective income tax expense rate | 23.8 | % | 40.3 | % | |||
After-tax margin | 4.8 | % | 2.3 | % |
March 31, | December 31, | ||||||
2019 | 2018 | ||||||
(Dollars in millions, except per-share amounts) | |||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 3,224 | $ | 2,826 | |||
Investments | 1,508 | 1,681 | |||||
Receivables | 1,359 | 1,330 | |||||
Prepaid expenses and other current assets | 124 | 149 | |||||
Derivative asset | 516 | 476 | |||||
Total current assets | 6,731 | 6,462 | |||||
Property, equipment, and capitalized software, net | 376 | 241 | |||||
Goodwill and intangible assets, net | 185 | 190 | |||||
Restricted investments | 100 | 120 | |||||
Deferred income taxes | 76 | 117 | |||||
Other assets | 111 | 24 | |||||
$ | 7,579 | $ | 7,154 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Medical claims and benefits payable | $ | 1,995 | $ | 1,961 | |||
Amounts due government agencies | 932 | 967 | |||||
Accounts payable and accrued liabilities | 444 | 390 | |||||
Deferred revenue | 207 | 211 | |||||
Current portion of long-term debt | 198 | 241 | |||||
Derivative liability | 516 | 476 | |||||
Total current liabilities | 4,292 | 4,246 | |||||
Long-term debt | 1,121 | 1,020 | |||||
Finance lease liabilities | 234 | 197 | |||||
Other long-term liabilities | 97 | 44 | |||||
Total liabilities | 5,744 | 5,507 | |||||
Stockholders’ equity: | |||||||
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 63 million shares at March 31, 2019 and 62 million shares at December 31, 2018 | — | — | |||||
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding | — | — | |||||
Additional paid-in capital | 543 | 643 | |||||
Accumulated other comprehensive loss | (3 | ) | (8 | ) | |||
Retained earnings | 1,295 | 1,012 | |||||
Total stockholders’ equity | 1,835 | 1,647 | |||||
$ | 7,579 | $ | 7,154 |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
(In millions) | |||||||
Operating activities: | |||||||
Net income | $ | 198 | $ | 107 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization | 25 | 37 | |||||
Deferred income taxes | 15 | (6 | ) | ||||
Share-based compensation | 9 | 6 | |||||
Amortization of convertible senior notes and finance lease liabilities | 3 | 7 | |||||
(Gain) loss on debt extinguishment | (3 | ) | 10 | ||||
Non-cash restructuring costs | — | 17 | |||||
Other, net | 3 | 2 | |||||
Changes in operating assets and liabilities: | |||||||
Receivables | (29 | ) | (83 | ) | |||
Prepaid expenses and other current assets | 20 | (239 | ) | ||||
Medical claims and benefits payable | 34 | (163 | ) | ||||
Amounts due government agencies | (35 | ) | 172 | ||||
Accounts payable and accrued liabilities | (30 | ) | 319 | ||||
Deferred revenue | (4 | ) | 130 | ||||
Income taxes | 43 | 78 | |||||
Net cash provided by operating activities | 249 | 394 | |||||
Investing activities: | |||||||
Purchases of investments | (185 | ) | (389 | ) | |||
Proceeds from sales and maturities of investments | 366 | 543 | |||||
Purchases of property, equipment, and capitalized software | (6 | ) | (4 | ) | |||
Other, net | (4 | ) | (5 | ) | |||
Net cash provided by investing activities | 171 | 145 | |||||
Financing activities: | |||||||
Repayment of principal amount of 1.125% Convertible Notes | (46 | ) | — | ||||
Cash paid for partial settlement of 1.125% Conversion Option | (115 | ) | — | ||||
Cash received for partial termination of 1.125% Call Option | 115 | — | |||||
Cash paid for partial termination of 1.125% Warrants | (103 | ) | — | ||||
Proceeds from borrowings under Term Loan | 100 | — | |||||
Other, net | 1 | (5 | ) | ||||
Net cash used in financing activities | (48 | ) | (5 | ) | |||
Net increase in cash, cash equivalents, and restricted cash and cash equivalents | 372 | 534 | |||||
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | 2,926 | 3,290 | |||||
Cash, cash equivalents, and restricted cash and cash equivalents at end of period | $ | 3,298 | $ | 3,824 |
March 31, 2019 | December 31, 2018 | March 31, 2018 | ||||||
Ending Membership by Government Program: | ||||||||
Temporary Assistance for Needy Families (“TANF”) and Children’s Health Insurance Program (“CHIP”) | 2,016,000 | 2,295,000 | 2,435,000 | |||||
Medicaid Expansion | 596,000 | 660,000 | 662,000 | |||||
Aged, Blind or Disabled (“ABD”) | 352,000 | 406,000 | 411,000 | |||||
Total Medicaid | 2,964,000 | 3,361,000 | 3,508,000 | |||||
Medicare-Medicaid Plan (“MMP”) - Integrated | 56,000 | 54,000 | 56,000 | |||||
Medicare Special Needs Plans | 41,000 | 44,000 | 44,000 | |||||
Total Medicare | 97,000 | 98,000 | 100,000 | |||||
Total Medicaid and Medicare | 3,061,000 | 3,459,000 | 3,608,000 | |||||
Marketplace | 332,000 | 362,000 | 453,000 | |||||
3,393,000 | 3,821,000 | 4,061,000 | ||||||
Ending Membership by Health Plan: | ||||||||
California | 600,000 | 608,000 | 656,000 | |||||
Florida (1) | 144,000 | 313,000 | 414,000 | |||||
Illinois | 219,000 | 224,000 | 151,000 | |||||
Michigan | 369,000 | 383,000 | 388,000 | |||||
New Mexico (1) | 27,000 | 222,000 | 250,000 | |||||
Ohio | 295,000 | 302,000 | 328,000 | |||||
Puerto Rico | 207,000 | 252,000 | 316,000 | |||||
South Carolina | 126,000 | 120,000 | 117,000 | |||||
Texas | 377,000 | 423,000 | 476,000 | |||||
Washington | 815,000 | 781,000 | 779,000 | |||||
Other (2) | 214,000 | 193,000 | 186,000 | |||||
3,393,000 | 3,821,000 | 4,061,000 |
(1) | As reported throughout 2018, the Company’s Medicaid contracts in New Mexico and in all but two regions in Florida terminated in late 2018 and early 2019. During 2019, the Company continues to serve Medicare and Marketplace members in both Florida and New Mexico, as well as Medicaid members in two regions in Florida. |
(2) | “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results. |
Three Months Ended March 31, 2019 | |||||||||||||||||||||||||
Member Months (1) | Premium Revenue | Medical Care Costs | MCR (2) | Medical Margin | |||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||
TANF and CHIP | 6.2 | $ | 1,173 | $ | 189.36 | $ | 1,022 | $ | 165.05 | 87.2 | % | $ | 151 | ||||||||||||
Medicaid Expansion | 1.8 | 664 | 369.62 | 594 | 330.45 | 89.4 | 70 | ||||||||||||||||||
ABD | 1.1 | 1,167 | 1,068.43 | 1,042 | 953.48 | 89.2 | 125 | ||||||||||||||||||
Total Medicaid | 9.1 | 3,004 | 330.75 | 2,658 | 292.60 | 88.5 | 346 | ||||||||||||||||||
MMP | 0.2 | 388 | 2,355.29 | 333 | 2,026.83 | 86.1 | 55 | ||||||||||||||||||
Medicare | 0.1 | 163 | 1,284.70 | 133 | 1,047.78 | 81.6 | 30 | ||||||||||||||||||
Total Medicare | 0.3 | 551 | 1,889.47 | 466 | 1,600.84 | 84.7 | 85 | ||||||||||||||||||
Total Medicaid and Medicare | 9.4 | 3,555 | 379.19 | 3,124 | 333.26 | 87.9 | 431 | ||||||||||||||||||
Marketplace | 1.0 | 397 | 393.53 | 247 | 244.61 | 62.2 | 150 | ||||||||||||||||||
10.4 | $ | 3,952 | $ | 380.59 | $ | 3,371 | $ | 324.65 | 85.3 | % | $ | 581 |
Three Months Ended March 31, 2018 | |||||||||||||||||||||||||
Member Months | Premium Revenue | Medical Care Costs | MCR | Medical Margin | |||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||
TANF and CHIP | 7.4 | $ | 1,373 | $ | 185.14 | $ | 1,272 | $ | 171.56 | 92.7 | % | $ | 101 | ||||||||||||
Medicaid Expansion | 2.0 | 752 | 372.75 | 641 | 317.46 | 85.2 | 111 | ||||||||||||||||||
ABD | 1.2 | 1,254 | 1,014.23 | 1,155 | 934.55 | 92.1 | 99 | ||||||||||||||||||
Total Medicaid | 10.6 | 3,379 | 316.69 | 3,068 | 287.56 | 90.8 | 311 | ||||||||||||||||||
MMP | 0.2 | 357 | 2,137.88 | 305 | 1,824.21 | 85.3 | 52 | ||||||||||||||||||
Medicare | 0.1 | 157 | 1,188.97 | 131 | 994.81 | 83.7 | 26 | ||||||||||||||||||
Total Medicare | 0.3 | 514 | 1,718.61 | 436 | 1,457.75 | 84.8 | 78 | ||||||||||||||||||
Total Medicaid and Medicare | 10.9 | 3,893 | 354.94 | 3,504 | 319.48 | 90.0 | 389 | ||||||||||||||||||
Marketplace | 1.4 | 430 | 312.87 | 218 | 158.40 | 50.6 | 212 | ||||||||||||||||||
12.3 | $ | 4,323 | $ | 350.25 | $ | 3,722 | $ | 301.55 | 86.1 | % | $ | 601 |
(1) | A member month is defined as the aggregate of each month’s ending membership for the period presented. |
(2) | The MCR represents medical costs as a percentage of premium revenue. |
Three Months Ended March 31, 2019 | |||||||||||||||||||||||||
Member Months | Premium Revenue | Medical Care Costs | MCR | Medical Margin | |||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||
California | 1.7 | $ | 499 | $ | 299.83 | $ | 448 | $ | 269.33 | 89.8 | % | $ | 51 | ||||||||||||
Florida | 0.4 | 162 | 387.48 | 127 | 303.05 | 78.2 | 35 | ||||||||||||||||||
Illinois | 0.7 | 227 | 348.04 | 185 | 282.70 | 81.2 | 42 | ||||||||||||||||||
Michigan | 1.1 | 395 | 363.04 | 326 | 299.99 | 82.6 | 69 | ||||||||||||||||||
Ohio | 0.9 | 590 | 659.09 | 537 | 600.07 | 91.0 | 53 | ||||||||||||||||||
Puerto Rico | 0.6 | 102 | 165.02 | 90 | 145.38 | 88.1 | 12 | ||||||||||||||||||
South Carolina | 0.4 | 136 | 363.14 | 115 | 308.87 | 85.1 | 21 | ||||||||||||||||||
Texas | 0.6 | 599 | 902.56 | 532 | 801.53 | 88.8 | 67 | ||||||||||||||||||
Washington | 2.4 | 614 | 258.41 | 586 | 246.69 | 95.5 | 28 | ||||||||||||||||||
Other (1) (2) | 0.6 | 231 | 370.26 | 178 | 285.13 | 77.0 | 53 | ||||||||||||||||||
9.4 | $ | 3,555 | $ | 379.19 | $ | 3,124 | $ | 333.26 | 87.9 | % | $ | 431 | |||||||||||||
Three Months Ended March 31, 2018 | |||||||||||||||||||||||||
Member Months | Premium Revenue | Medical Care Costs | MCR | Medical Margin | |||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||
California | 1.8 | $ | 494 | $ | 272.61 | $ | 412 | $ | 227.31 | 83.4 | % | $ | 82 | ||||||||||||
Florida | 1.0 | 382 | 351.58 | 345 | 317.41 | 90.3 | 37 | ||||||||||||||||||
Illinois | 0.5 | 141 | 298.17 | 122 | 257.50 | 86.4 | 19 | ||||||||||||||||||
Michigan | 1.1 | 376 | 336.64 | 331 | 296.19 | 88.0 | 45 | ||||||||||||||||||
New Mexico (2) | 0.7 | 319 | 466.17 | 310 | 453.30 | 97.2 | 9 | ||||||||||||||||||
Ohio | 0.9 | 551 | 576.60 | 460 | 481.26 | 83.5 | 91 | ||||||||||||||||||
Puerto Rico | 1.0 | 186 | 193.13 | 174 | 181.39 | 93.9 | 12 | ||||||||||||||||||
South Carolina | 0.3 | 122 | 348.08 | 104 | 297.52 | 85.5 | 18 | ||||||||||||||||||
Texas | 0.7 | 562 | 809.90 | 519 | 747.53 | 92.3 | 43 | ||||||||||||||||||
Washington | 2.3 | 584 | 256.66 | 574 | 252.41 | 98.3 | 10 | ||||||||||||||||||
Other (1) | 0.6 | 176 | 314.93 | 153 | 273.36 | 86.8 | 23 | ||||||||||||||||||
10.9 | $ | 3,893 | $ | 354.94 | $ | 3,504 | $ | 319.48 | 90.0 | % | $ | 389 |
(1) | “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results. |
(2) | In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results. |
Three Months Ended March 31, 2019 | |||||||||||||||||||||||||
Member Months | Premium Revenue | Medical Care Costs | MCR | Medical Margin | |||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||
California | 0.1 | $ | 56 | $ | 342.00 | $ | 33 | $ | 201.46 | 58.9 | % | $ | 23 | ||||||||||||
Florida | 0.2 | 61 | 421.17 | 26 | 177.31 | 42.1 | 35 | ||||||||||||||||||
Michigan | — | 10 | 467.25 | 5 | 211.50 | 45.3 | 5 | ||||||||||||||||||
Ohio | — | 30 | 853.87 | 15 | 448.51 | 52.5 | 15 | ||||||||||||||||||
Texas | 0.6 | 148 | 306.36 | 109 | 226.36 | 73.9 | 39 | ||||||||||||||||||
Washington | — | 47 | 711.60 | 29 | 435.90 | 61.3 | 18 | ||||||||||||||||||
Other (1) | 0.1 | 45 | 476.11 | 30 | 314.70 | 66.1 | 15 | ||||||||||||||||||
1.0 | $ | 397 | $ | 393.53 | $ | 247 | $ | 244.61 | 62.2 | % | $ | 150 | |||||||||||||
Three Months Ended March 31, 2018 | |||||||||||||||||||||||||
Member Months | Premium Revenue | Medical Care Costs | MCR | Medical Margin | |||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||
California | 0.2 | $ | 49 | $ | 253.93 | $ | 31 | $ | 162.64 | 64.0 | % | $ | 18 | ||||||||||||
Florida | 0.2 | 45 | 271.12 | (16 | ) | (95.60 | ) | (35.3 | ) | 61 | |||||||||||||||
Michigan | 0.1 | 13 | 224.11 | 9 | 144.16 | 64.3 | 4 | ||||||||||||||||||
New Mexico | 0.1 | 34 | 438.67 | 19 | 246.50 | 56.2 | 15 | ||||||||||||||||||
Ohio | 0.1 | 26 | 403.44 | 17 | 262.87 | 65.2 | 9 | ||||||||||||||||||
Texas | 0.7 | 229 | 308.74 | 146 | 196.89 | 63.8 | 83 | ||||||||||||||||||
Washington | — | 39 | 526.36 | 30 | 405.40 | 77.0 | 9 | ||||||||||||||||||
Other (2) | — | (5 | ) | NM | (18 | ) | NM | NM | 13 | ||||||||||||||||
1.4 | $ | 430 | $ | 312.87 | $ | 218 | $ | 158.40 | 50.6 | % | $ | 212 |
(1) | “Other” includes the New Mexico, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results in 2019. |
(2) | “Other” includes the Utah and Wisconsin health plans, where the Company did not participate in the Marketplace in 2018. Therefore, the ratios for 2018 periods are not meaningful (NM). |
Three Months Ended March 31, 2019 | |||||||||||||||||||||||||
Member Months | Premium Revenue | Medical Care Costs | MCR | Medical Margin | |||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||
California | 1.8 | $ | 555 | $ | 303.64 | $ | 481 | $ | 263.20 | 86.7 | % | $ | 74 | ||||||||||||
Florida | 0.6 | 223 | 396.13 | 153 | 270.76 | 68.4 | 70 | ||||||||||||||||||
Illinois | 0.7 | 227 | 348.04 | 185 | 282.70 | 81.2 | 42 | ||||||||||||||||||
Michigan | 1.1 | 405 | 365.09 | 331 | 298.25 | 81.7 | 74 | ||||||||||||||||||
Ohio | 0.9 | 620 | 666.41 | 552 | 594.38 | 89.2 | 68 | ||||||||||||||||||
Puerto Rico | 0.6 | 102 | 165.02 | 90 | 145.38 | 88.1 | 12 | ||||||||||||||||||
South Carolina | 0.4 | 136 | 363.14 | 115 | 308.87 | 85.1 | 21 | ||||||||||||||||||
Texas | 1.2 | 747 | 651.67 | 641 | 559.49 | 85.9 | 106 | ||||||||||||||||||
Washington | 2.4 | 661 | 270.72 | 615 | 251.83 | 93.0 | 46 | ||||||||||||||||||
Other (1) (2) | 0.7 | 276 | 384.08 | 208 | 288.99 | 75.2 | 68 | ||||||||||||||||||
10.4 | $ | 3,952 | $ | 380.59 | $ | 3,371 | $ | 324.65 | 85.3 | % | $ | 581 | |||||||||||||
Three Months Ended March 31, 2018 | |||||||||||||||||||||||||
Member Months | Premium Revenue | Medical Care Costs | MCR | Medical Margin | |||||||||||||||||||||
Total | PMPM | Total | PMPM | ||||||||||||||||||||||
California | 2.0 | $ | 543 | $ | 270.80 | $ | 443 | $ | 221.03 | 81.6 | % | $ | 100 | ||||||||||||
Florida | 1.2 | 427 | 340.91 | 329 | 262.65 | 77.0 | 98 | ||||||||||||||||||
Illinois | 0.5 | 141 | 298.17 | 122 | 257.50 | 86.4 | 19 | ||||||||||||||||||
Michigan | 1.2 | 389 | 331.08 | 340 | 288.68 | 87.2 | 49 | ||||||||||||||||||
New Mexico (2) | 0.8 | 353 | 463.33 | 329 | 431.94 | 93.2 | 24 | ||||||||||||||||||
Ohio | 1.0 | 577 | 565.62 | 477 | 467.41 | 82.6 | 100 | ||||||||||||||||||
Puerto Rico | 1.0 | 186 | 193.13 | 174 | 181.39 | 93.9 | 12 | ||||||||||||||||||
South Carolina | 0.3 | 122 | 348.08 | 104 | 297.52 | 85.5 | 18 | ||||||||||||||||||
Texas | 1.4 | 791 | 551.28 | 665 | 463.37 | 84.1 | 126 | ||||||||||||||||||
Washington | 2.3 | 623 | 265.20 | 604 | 257.25 | 97.0 | 19 | ||||||||||||||||||
Other (1) | 0.6 | 171 | 305.94 | 135 | 240.95 | 78.8 | 36 | ||||||||||||||||||
12.3 | $ | 4,323 | $ | 350.25 | $ | 3,722 | $ | 301.55 | 86.1 | % | $ | 601 |
(1) | “Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results. |
(2) | In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results. |
Three Months Ended March 31, | |||||||||||||||||||||
2019 | 2018 | ||||||||||||||||||||
Amount | PMPM | % of Total | Amount | PMPM | % of Total | ||||||||||||||||
Fee for service | $ | 2,514 | $ | 242.12 | 74.6 | % | $ | 2,745 | $ | 222.38 | 73.8 | % | |||||||||
Pharmacy | 413 | 39.73 | 12.2 | 583 | 47.25 | 15.6 | |||||||||||||||
Capitation | 285 | 27.46 | 8.5 | 312 | 25.28 | 8.4 | |||||||||||||||
Other | 159 | 15.34 | 4.7 | 82 | 6.64 | 2.2 | |||||||||||||||
$ | 3,371 | $ | 324.65 | 100.0 | % | $ | 3,722 | $ | 301.55 | 100.0 | % |
March 31, | December 31, | ||||||
2019 | 2018 | ||||||
Fee-for-service claims incurred but not paid (IBNP) | $ | 1,411 | $ | 1,562 | |||
Pharmacy payable | 114 | 115 | |||||
Capitation payable | 59 | 52 | |||||
Other (1) | 411 | 232 | |||||
$ | 1,995 | $ | 1,961 |
(1) | “Other” medical claims and benefits payable include amounts payable to certain providers for which the Company acts as an intermediary on behalf of various state agencies without assuming financial risk. Such receipts and payments do not impact the Company’s consolidated statements of income. As of March 31, 2019 and December 31, 2018, the Company had recorded non-risk provider payables of approximately $278 million and $107 million, respectively. |
Three Months Ended March 31, | Year Ended December 31, 2018 | ||||||||||
2019 | 2018 | ||||||||||
Medical claims and benefits payable, beginning balance | $ | 1,961 | $ | 2,192 | $ | 2,192 | |||||
Components of medical care costs related to: | |||||||||||
Current period | 3,560 | 4,033 | 15,478 | ||||||||
Prior period (1) | (189 | ) | (311 | ) | (341 | ) | |||||
Total medical care costs | 3,371 | 3,722 | 15,137 | ||||||||
Change in non-risk provider payables | 171 | 45 | 13 | ||||||||
Payments for medical care costs related to: | |||||||||||
Current period | 2,197 | 2,498 | 13,671 | ||||||||
Prior period | 1,311 | 1,438 | 1,710 | ||||||||
Total paid | 3,508 | 3,936 | 15,381 | ||||||||
Medical claims and benefits payable, ending balance | $ | 1,995 | $ | 2,023 | $ | 1,961 | |||||
Days in claims payable, fee for service (2) | 52 | 53 | 53 |
(1) | March 31, 2018, includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $70 million. December 31, 2018, includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $81 million. |
(2) | Claims payable includes primarily IBNP. It also includes certain fee-for-service payables reported in “Other” medical claims and benefits payable amounting to $51 million, $22 million and $43 million, as of March 31, 2019, March 31, 2018, and December 31, 2018, respectively. |
Three Months Ended March 31, | |||||||||||||||
2019 | 2018 | ||||||||||||||
Amount | Per Diluted Share (1) | Amount | Per Diluted Share (1) | ||||||||||||
Marketplace CSR subsidies, for 2017 dates of service | $ | — | $ | — | $ | 70 | $ | 0.83 | |||||||
Restructuring costs | (3 | ) | (0.03 | ) | (25 | ) | (0.30 | ) | |||||||
Gain (loss) on debt extinguishment | 3 | 0.03 | (10 | ) | (0.15 | ) | |||||||||
$ | — | $ | — | $ | 35 | $ | 0.38 |
(1) | Except for permanent differences between GAAP and tax (such as certain expenses that are not deductible for tax purposes), per diluted share amounts are generally calculated at the statutory income tax rate of 22.6% and 22% for the first quarter of 2019 and 2018, respectively. |
Three Months Ended March 31, | |||||||
2019 | 2018 | ||||||
Net income | $ | 198 | $ | 107 | |||
Adjustments: | |||||||
Depreciation, and amortization of intangible assets and capitalized software | 25 | 34 | |||||
Interest expense | 23 | 33 | |||||
Income tax expense | 62 | 72 | |||||
EBITDA | $ | 308 | $ | 246 |
Three Months Ended March 31, | |||||||||||||||
2019 | 2018 | ||||||||||||||
Amount | Per Diluted Share | Amount | Per Diluted Share | ||||||||||||
Net income | $ | 198 | $ | 2.99 | $ | 107 | $ | 1.64 | |||||||
Adjustment: | |||||||||||||||
Amortization of intangible assets | 5 | 0.07 | 5 | 0.08 | |||||||||||
Income tax effect (1) | (1 | ) | (0.02 | ) | (1 | ) | (0.01 | ) | |||||||
Amortization of intangible assets, net of tax effect | 4 | 0.05 | 4 | 0.07 | |||||||||||
Adjusted net income | $ | 202 | $ | 3.04 | $ | 111 | $ | 1.71 |
(1) | Income tax effect of adjustments calculated at the blended federal and state statutory tax rate of 22.6% and 22% for 2019 and 2018, respectively. |
Low End | High End | ||||||
(In millions) | |||||||
Net income | $ | 680 | $ | 710 | |||
Adjustments: | |||||||
Depreciation, and amortization of intangible assets and capitalized software | 90 | 90 | |||||
Interest expense | 90 | 90 | |||||
Income tax expense | 220 | 230 | |||||
EBITDA | $ | 1,080 | $ | 1,120 |